Results 21 to 30 of about 6,442 (232)

Review of the clinical case of a patient with microcarcinoma of the thyroid gland

open access: yesКлиническая и экспериментальная тиреоидология, 2020
Before us is the story of young woman who actively monitored the condition of the thyroid gland, due to the accidental detection of antibodies to the thyroid tissue. After the detection of a tumor (7 mm), hemi thyroidectomy was conducted.
Galina A. Melnichenko   +2 more
doaj   +1 more source

Prediction for recurrence following antithyroid drug therapy for Graves’ hyperthyroidism [PDF]

open access: yesArchives of Endocrinology and Metabolism, 2023
Objective: A common problem with antithyroid drugs (ATD) treatment in patients with Graves’ disease (GD) is the high recurrence rate after drug withdrawal. Identifying risk factors for recurrence is crucial in clinical practice.
Huan Weng   +3 more
doaj   +1 more source

Cancer complicating systemic lupus erythematosus--a dichotomy emerging from a nested case-control study [PDF]

open access: yes, 2013
We determined whether any individual cancers are increased or decreased in a cohort of 595 patients with systemic lupus erythematosus (SLE) followed for up to 32 years at the University College London Hospitals Lupus Clinic, looking for any associated ...
Dey, D, Isenberg, DA, Kenu, E
core   +1 more source

Neurotoxicity [PDF]

open access: yes, 2014
Neurotoxicity refers to the direct or indirect effect of chemicals that disrupt the nervous system of humans or animals. Numerous chemicals can produce neurotoxic diseases in humans, and many more are used as experimental tools to disturb or damage the ...
Brust   +15 more
core   +2 more sources

Pediatric Graves’ disease: insights into clinical characteristics and treatment outcomes [PDF]

open access: yesArchives of Endocrinology and Metabolism
Objective: To identify early manifestations of Graves’ disease in young patients and its treatment outcomes. Subjects and methods: This was a hospital-based review of case records of 47 children (aged 1 month to 18 years) with Graves’ disease from 2011 ...
Akshatha Anand   +2 more
doaj   +1 more source

Hemodynamic Instability during Thyroidectomy in Graves’ Disease

open access: yesJournal of Investigative Surgery, 2022
Background The aim of this study was to investigate the changes in vital signs and hemodynamic status that occur in patients during the intraoperative course of thyroidectomy in Graves’ Disease (GD).
Sami Acar   +6 more
doaj   +1 more source

The Clinical Significance of Subclinical Thyroid Dysfunction. [PDF]

open access: yes, 2008
Subclinical thyroid disease (SCTD) is defined as serum free T(4) and free T(3) levels within their respective reference ranges in the presence of abnormal serum TSH levels.
BIONDI, BERNADETTE, COOPER DS
core   +1 more source

Methimazole-Induced Aplastic Anemia with Concomitant Hepatitis in a Young Filipina with Graves’ Disease

open access: yesJournal of the ASEAN Federation of Endocrine Societies, 2019
A 34-year-old Filipino with Graves’ disease on methimazole came in due to fever, sore throat and jaundice. Patient was initially diagnosed with methimazole induced agranulocytosis and drug induced liver injury.
Natalia Wijaya, Celeste Ong-Ramos
doaj   +1 more source

Evaluation of renal perfusion in hyperthyroid cats before and after radioiodine treatment [PDF]

open access: yes, 2017
Background: Hyperthyroidism and chronic kidney disease (CKD) are common in elderly cats. Consequently, both diseases often occur concurrently. Furthermore, renal function is affected by thyroid status. Because changes in renal perfusion play an important
Adams   +34 more
core   +2 more sources

Thyrotoxicosis in a 13-year-old girl following pituitary adenectomy for Cushing's disease. [PDF]

open access: yes, 2017
To access publisher's full text version of this article, please click on the hyperlink in Additional Links field or click on the hyperlink at the top of the page marked FilesOur objective is to report a case of thyrotoxicosis following pituitary ...
Barnes   +16 more
core   +1 more source

Home - About - Disclaimer - Privacy